TGF-β/Smad Signalling in Neurogenesis: Implications for Neuropsychiatric Diseases
Open accessThe DOI matches its Crossref record; 163 of the 164 references it cites were found in a registry or an index.
Abstract
TGF-β/Smad signalling has been the subject of extensive research due to its role in the cell cycle and carcinogenesis. Modifications to the TGF-β/Smad signalling pathway have been found to produce disparate effects on neurogenesis. We review the current research on canonical and non-canonical TGF-β/Smad signalling pathways and their functions in neurogenesis. We also examine the observed role of neurogenesis in neuropsychiatric disorders and the relationship between TGF-β/Smad signalling and neurogenesis in response to stressors. Overlapping mechanisms of cell proliferation, neurogenesis, and the development of mood disorders in response to stressors suggest that TGF-β/Smad signalling is an important regulator of stress response and is implicated in the behavioural outcomes of mood disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In silico pathway analysis enabled us to identify 21 pathways associated with the 228 miRNAs and their interacting genes such as TGFBR2, TNF, MAPK, SMAD, including the TGF-β, glutamatergic synapse, and long-term depression pathways, associated with major depressive disorder, as well as the MAPK signaling pathway reported in previous studies [30,59,63,64,65,66,67,68].”
From Multiple Pre-Treatment miRNAs Levels in Untreated Major Depressive Disorder Patients Predict Early Response to Antidepressants and Interact with Key Pathways (2022) · cites this paper as [65]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In silico pathway analysis enabled us to identify 21 pathways associated with the 228 miRNAs and their interacting genes such as TGFBR2, TNF, MAPK, SMAD, including the TGF-β, glutamatergic synapse, and long-term depression pathways, associated with major depressive disorder, as well as the MAPK signaling pathway reported in previous studies [30,59,63,64,65,66,67,68].”
In the citing paper
“Signaling via the TGF-β/Smad pathway is essential in regulating stress response and has also been implicated in developing mood disorders [216].”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [216]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Massagué, J., Blain, S. W., & Lo, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)00121-5 · Cited by 2,385
Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967 · cited 1×
“This is consistently supported by in vitro and in vivo data, which demonstrated lower survivability of TGF-β knockout neurones [46], and embryonic lethality, increased neuronal apoptosis and other abnormalities such as reduced synaptic integrity and microgliosis, observed in TGF-β-null mice [46,47].”
ResultHippocampal atrophy in recurrent major depression
Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3908 · Cited by 1,932
Dynamics of hippocampal neurogenesis in adult humans
Spalding, K. L., Bergmann, O., Alkass, K., Bernard, S., Salehpour, M., Huttner, H. B., Boström, E., Westerlund, I., Vial, C., Buchholz, B. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.002 · Cited by 1,841
Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Nakao, A., Afrakhte, M., Morn, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N.-E., Heldin, C.-H., et al. (1997) · Nature · doi:10.1038/39369 · Cited by 1,809
Cited by
Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets
Di, X., Gao, X., Peng, L., Ai, J., Jin, X., Qi, S., Li, H., Wang, K., & Luo, D. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01501-9 · Cited by 622
Selected biomarkers of depression: what are the effects of cytokines and inflammation
Harsanyi, S., Kupcova, I., Danisovic, L., & Klein, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010578 · Cited by 299
TGF-β as a Key Modulator of Astrocyte Reactivity: Disease Relevance and Therapeutic Implications
Luo, J. (2022) · Biomedicines · doi:10.3390/biomedicines10051206 · Cited by 146
Liang, G., Kow, A. S. F., Yusof, R., Tham, C. L., Ho, Y.-C., & Lee, M. T. (2024) · Biomedicines · doi:10.3390/biomedicines12010184 · Cited by 68
“…growth via the TGF-β /TAK1 signal pathway; (3) TGF-β was involved in neuronal differentiation and axon growth through the TGF-β /MAPK signal pathway; (4) TGF-β 2 increased CREB phosphorylation in hippocampal cells, which mediated the long-term improvement of depressive behavior by TGF-β 2 [116].”
BackgroundRole of transforming growth factor-β in peripheral nerve regeneration
Ding, Z., Jiang, M., Qian, J., Gu, D., Bai, H., Cai, M., & Yao, D. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.377588 · Cited by 49
“Dysregulation of TGF-β signaling is linked to the development of autoimmune, cardiovascular, and neurodegenerative diseases and cancer (Wallace et al., 2018; Hiew et al., 2021; Cheng et al., 2023).”
Background
Metadata
- Authors
- Hiew, L.-F., Poon, C.-H., You, H.-Z., & Lim, L.-W.
- Affiliations
- University of Hong Kong (HK)
- Corresponding author
- Lim, Lee-Wei
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2021-06-03
- Volume
- 10
- Issue
- 6
- Pages
- 1382
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC8226492
- OpenAlex
- W3166157419
- Cited by
- 71
- References
- 164
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 20 · 2023: 11 · 2022: 18 · 2021: 1
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- TGF-β/Smad signaling, neurogenesis, neuropsychiatric disorders, mood disorders, stress response, cell proliferation, behavioural outcomes
- MeSH terms
- Humans, Nervous System Diseases, Signal Transduction, Transforming Growth Factor beta, Mood Disorders, Smad Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.